In addition to another corona wave, experts are warning of an increase in flu cases. There is a risk of co-infection with the pathogens.
Munich – Last winter hardly any flu cases were registered. The corona protective measures played a major role in this. You shouldn’t rely on the wave failing again this season. On the contrary: researchers are warning of a double pandemic. Not only are the corona numbers expected to rise in autumn and winter, but also an increase in influenza cases.
Autumn and winter: RKI warns of increased infections
For example, the Robert Koch Institute warns in its latest “ControlCovid”-Paper against increased disease incidence in autumn and winter. Care facilities in particular could be affected. “One conceivable scenario is that the very old people can have more vaccination breakthroughs the longer they have been vaccinated, so that severe Covid-19 outbreaks can occur in nursing homes,” the report says.
In addition, the RKI warns of “an additional expected exposure to acute respiratory infections that did not circulate in the population in the 2020/21 season due to the contact-reducing measures, such as influenza and RSV. In the USA such a “twinkemic”, as it is called there, seems to be emerging, ie the simultaneous infection with two different pathogens.
Difficult treatment: corona and flu co-infection
Infectious disease and international health expert Dr. Patrick EH Jackson of the University of Virginia told Medical News Today : “There have been relatively few studies of the co-infection of COVID-19 and influenza in humans. However, there is some data to suggest that results could be worse if a patient has both viruses at the same time. A co-infection would also make the treatment of hospital patients more difficult. ”
In order to prevent a double infection, the RKI and the Stiko therefore particularly call for vaccinations in old people’s and nursing homes. Vaccinations against influenza and pneumococci as well as a booster (“booster”) against Covid-19 are recommended for people at risk and residents. The US company Merck is meanwhile giving hope in the fight against severe corona courses. The drug “Molnupiravir” is said to cut the risk of severe disease in half. (jsch)
List of rubric lists: © Wolfgang Kumm / dpa